Literature DB >> 4905910

Aetiology of migraine and prevention with carbamazepine (Tegretol): results of a double-blind, cross-over study.

H Rompel, P W Bauermeister.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4905910

Source DB:  PubMed          Journal:  S Afr Med J


× No keyword cloud information.
  17 in total

Review 1.  Practical considerations for the treatment of elderly patients with migraine.

Authors:  Paola Sarchielli; Maria Luisa Mancini; Paolo Calabresi
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

2.  A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients.

Authors:  Elham Bidabadi; Mehryar Mashouf
Journal:  Paediatr Drugs       Date:  2010-08-01       Impact factor: 3.022

Review 3.  WITHDRAWN: Drugs for preventing migraine headaches in children.

Authors:  Suresh Victor; Steven Ryan
Journal:  Cochrane Database Syst Rev       Date:  2014-07-11

4.  Acute renal failure from carbamazepine.

Authors:  D P Nicholls; M Yasin
Journal:  Br Med J       Date:  1972-11-25

5.  Vascular responses in the hands of patients suffering from migraine.

Authors:  J A Downey; D B Frewin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-04       Impact factor: 10.154

Review 6.  Anticonvulsant drugs for management of pain: a systematic review.

Authors:  H McQuay; D Carroll; A R Jadad; P Wiffen; A Moore
Journal:  BMJ       Date:  1995-10-21

7.  Antiepileptic Drug Therapy in Migraine Headache.

Authors:  Steve D. Wheeler
Journal:  Curr Treat Options Neurol       Date:  2002-09       Impact factor: 3.598

Review 8.  Refining the Benefit/Risk Profile of Anti-Epileptic Drugs in Headache Disorders.

Authors:  Michael J Marmura; Aliza S Kumpinsky
Journal:  CNS Drugs       Date:  2018-08       Impact factor: 5.749

Review 9.  Anticonvulsants in migraine.

Authors:  William B Young; Hua Chiang Siow; Stephen D Silberstein
Journal:  Curr Pain Headache Rep       Date:  2004-06

10.  Optimizing prophylactic treatment of migraine: Subtypes and patient matching.

Authors:  Michel Dib
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.